Joint Diabetes Thalassaemia Clinic: An Effective New Model of Care

References

• De Sanctis V. Growth and puberty and its management in thalassaemia. Hormone Res. 2002;58(Suppl 1):72–79
   PubMedGoogle Scholar
• De Sanctis V, Eleftheriou A, Malaventura C. Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev. 2004;2(Suppl 2):249–255
   PubMedGoogle Scholar
• Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193
   PubMed Web of Science ®Google Scholar
• Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR, Thalassemia Clinical Research Network. Complications of β-thalassemia major in North America. Blood. 2004;104(1):34–39
   PubMed Web of Science ®Google Scholar
• Angelopoulos NG, Zervas A, Livadas S, et al. Reduced insulin secretion in normoglycemic patients with β-thalassemia major. Diabet Med. 2006;23(12):1327–1331
   PubMed Web of Science ®Google Scholar
• Merkel PA, Simonson DC, Amiel SA, et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med. 1988;318(13):809–814
   Google Scholar
• Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;162(3):139–146
   PubMed Web of Science ®Google Scholar
• Hafez M, Youssry I, El-Hamed FA, Ibrahim A. Abnormal glucose tolerance in β-thalassemia: assessment of risk factors. Hemoglobin. 2009;33(2):101–108
   PubMed Web of Science ®Google Scholar
• Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Prevalence of diabetes mellitus and impaired glucose tolerance in β-thalassemia patients with and without hepatitis C virus infection. Pediatric Endocrinol Rev. 2004;2(Suppl 2):282–284
   PubMedGoogle Scholar
• Monge L, Pinach S, Caramellino L, et al. The possible role of autoimmunity in the pathogenesis of diabetes in β-thalassemia major. Diabetes Metab. 2001;27(2 Pt 1):149–154
   PubMed Web of Science ®Google Scholar
• Labropoulou-Karatza C, Goritsas C, Fragopanagou H, et al. High prevalence of diabetes mellitus among adult β-thalassaemic patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 1999;11(9):1033–1036
   PubMedGoogle Scholar
• Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major. Br J Haematol. 2006;134(4):438–444
   PubMed Web of Science ®Google Scholar
• Christoforidis A, Perifanis V, Athanassiou-Metaxa M. Combined chelation therapy improves glucose metabolism in patients with β-thalassaemia major. Br J Haematol. 2006;135(2):271–272
   PubMed Web of Science ®Google Scholar
• Dhouib N, Turki Z, Mellouli F, et al. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major. La Tunisie Med. 2010;88(2):136
   Google Scholar
• Ladis V, Theodorides C, Palamidou F, et al. Regulation of glucose disturbances with glibenclamide in patients with thalassemia. Ann NY Acad Sci. 1998;850:471–474
   Google Scholar
• Mangiagli A, Campisi S, De Sanctis V, et al. Effects of acarbose in β-thalassaemia major patients with normal glucose tolerance and hyperinsulinism. Pediatr Endocrinol Rev. 2004;2(Suppl 2):272–275
   PubMedGoogle Scholar
• Confidential Enquiry into Maternal and Child Health: pregnancy in women with type 1 and type 2 diabetes in 2002–03, England, Wales and Northern Ireland. London: Confidential Enquiry into Maternal and Child Health (CEMACH), 2005. (Available at: http://hqip.org.uk/assets/NCAPOP-Library/CMACE-Reports/29.-2005-Pregnancy-in-women-with-type-1-and-type-2-diabetes-2002–2003.pdf) [last accessed 14 Nov 2013]
   Google Scholar
• Konrad D, Daneman D, Kirby M, Wherrett D. Cardiac failure after initiation of insulin treatment in diabetic patients with β-thalassemia major. J Pediatr. 2003;143(4):541–542
   Google Scholar
• Messina G, Colombo E, Cassinerio E, et al. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med. 2008;3(4):339–343
   Google Scholar
• Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153–161
   PubMed Web of Science ®Google Scholar
• Modell B, Khan M, Darlison M, et al. A national register for surveillance of inherited disorders: β thalassaemia in the United Kingdom. Bull World Health Organ. 2001;79(11):1006–1013
   PubMed Web of Science ®Google Scholar
• United Kingdom Thalassaemia Society. Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK, 2nd ed, 2008. Available at: http://www.ukts.org/pdf.html [last accessed 14 Nov 2013]
   Google Scholar
• NICE (National Institute for Health and Care Excellence) Guidance Type 1 diabetes. Diagnosis and management of type 1 diabetes in children, young people and adults. Available at: http://guidance.nice.org.uk/CG15 [last accessed 14 Nov 2013]
   Google Scholar
• NICE (National Institute for Health and Care Excellence) Guidance Type 2 diabetes (partially updated by CG87). Type 2 diabetes: the management of type 2 diabetes (update). http://www.nice.org.uk/CG66 [last accessed 14 Nov 2013]
   Google Scholar
• National Health Service Information Centre. National Diabetes Audit. Key findings about the quality of care for people with diabetes in England and Wales. Report for the audit period 2007–2008. Leeds: NHS IC, 2008. Available at: http://www.ic.nhs.uk/nda [last accessed 14 Nov 2013]
   Google Scholar
• St. Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105(2):855–861
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986
   PubMed Web of Science ®Google Scholar
• United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853
   PubMed Web of Science ®Google Scholar
• Loebstein R, Lehotay DC, Luo X, et al. Diabetic nephropathy in hypertransfused patients with β-thalassemia. The role of oxidative stress. Diabetes Care. 1998;21(8):1306–1309
   Google Scholar
• Quinn CT, Johnson VL, Kim HY, et al. Renal dysfunction in patients with thalassaemia. Br J Haematol. 2011;153(1):111–117
   PubMed Web of Science ®Google Scholar
• Bhandari S, Galanello R. Renal aspects of thalassaemia a changing paradigm. Eur J Haematol. 2012;89(3):187–197
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Parmeggiani F, Mingrone G, et al. Prevalence of retinopathy in diabetic thalassaemic patients. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):879–883
   Google Scholar
• Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009;114(14):2861–2868
   PubMed Web of Science ®Google Scholar
• Taher A, Isma’eel H, Mehio G, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96(4):488–491
   PubMed Web of Science ®Google Scholar
• Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in β thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99(2):76–79
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Poggiali E, Taher AT, Musallam KM. Hypercoagulability in β-thalassemia: a status quo. Expert Rev Hematol. 2012;5(5):505–511
   PubMed Web of Science ®Google Scholar
• Tantawy AA, Adly AA, El Maaty MG, Amin SA. Subclinical atherosclerosis in young β-thalassemia major patients. Hemoglobin. 2009;33(6):463–474
   PubMed Web of Science ®Google Scholar
• Dogan M, Citak EC. The evaluation of carotid intima-media thickness in children with β-thalassemia major. Cardiol Young. 2012;22(1):79–83
   PubMed Web of Science ®Google Scholar